Clinical trial
Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle…
NCT00465621 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00465621 |
|---|---|
| Title | Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension |
| Official title | Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Open-Angle Glaucoma, Ocular Hypertension |
| Intervention type | Drug |
| Interventions | Xalatan |
| Enrollment | 150 |
| Start date | Mar 1, 2007 |
| Primary completion | Jul 1, 2007 |
| First posted | Apr 25, 2007 |
| Last update posted | Jul 29, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: